Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction
Kanichiro Kobayashi(SHOWA Medical University), Tatsuo Suda(SHOWA Medical University), Kanji Higashio(Megmilk Snow Brand (Japan)), N. Nakagawa(SHOWA Medical University), Nobuyuki Udagawa(Matsumoto Dental University), Masahiko Kinosaki(Megmilk Snow Brand (Japan)), Shigeru Kotake(Tokyo Women's Medical University), Hisataka Yasuda(SHOWA Medical University), Naoyuki Takahashi(Matsumoto Dental University), T. John Martin(St Vincent's Hospital Melbourne), Kyoji Yamaguchi(Megmilk Snow Brand (Japan)), Tomonori Morinaga(SHOWA Medical University), Eijiro Jimi(Kyushu University), Nobuyuki Shima(SHOWA Medical University), Masamichi Takami(Showa University)
Cited by 1,309
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
OSTEOBLASTIC CELLS ARE INVOLVED IN OSTEOCLAST FORMATION
|Endocrinology|1988|945
Regulation of Osteoblast Differentiation Mediated by Bone Morphogenetic Proteins, Hedgehogs, and Cbfa1
|Endocrine Reviews|2000|665
Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation
|Journal of Bone and Mineral Research|1996|548